BIOTON S.A. (FRA:7U5)
Germany · Delayed Price · Currency is EUR 0.9080
+0.0120 (1.34%)
At close: Nov 28, 2025
BIOTON Company Description
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
The company offers recombinant human insulin; oral diabetic drugs; strips for measuring sugar in blood, as well as Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles.
BIOTON S.A. was founded in 1989 and is based in Ozarów Mazowiecki, Poland.
BIOTON S.A.
| Country | Poland |
| Founded | 1989 |
| Industry | Pharmaceutical Preparations |
| Employees | 364 |
| CEO | Jeremy Launders |
Contact Details
Address: ul. Poznanska 12 Ozarów Mazowiecki, 05-850 Poland | |
| Phone | 48 22 721 4000 |
| Website | bioton.pl |
Stock Details
| Ticker Symbol | 7U5 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jeremy Launders | Chief Executive Officer |
| Anna Grabowska | Chief Financial Officer |
| Michal Deptuch | Chief Operating Officer |